These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35202852)

  • 21. Naphthalimides and azonafides as promising anti-cancer agents.
    Ingrassia L; Lefranc F; Kiss R; Mijatovic T
    Curr Med Chem; 2009; 16(10):1192-213. PubMed ID: 19355879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vitro evaluation of naphthalimide-benzimidazole conjugates as potential antitumor agents.
    Singh I; Luxami V; Paul K
    Org Biomol Chem; 2019 May; 17(21):5349-5366. PubMed ID: 31099353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboranyl-1,8-naphthalimide intercalators induce lysosomal membrane permeabilization and ferroptosis in cancer cell lines.
    Rykowski S; Gurda-Woźna D; Fedoruk-Wyszomirska A; Orlicka-Płocka M; Kowalczyk A; Stączek P; Denel-Bobrowska M; Biniek-Antosiak K; Rypniewski W; Wyszko E; Olejniczak AB
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2171028. PubMed ID: 36715272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel naphthalimide polyamine derivatives as potential antitumor agents.
    Seliga R; Pilatova M; Sarissky M; Viglasky V; Walko M; Mojzis J
    Mol Biol Rep; 2013 Jun; 40(6):4129-37. PubMed ID: 23640101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxo-heterocyclic fused naphthalimides as antitumor agents: synthesis and biological evaluation.
    Tan S; Yin H; Chen Z; Qian X; Xu Y
    Eur J Med Chem; 2013 Apr; 62():130-8. PubMed ID: 23353750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, Synthesis and Antimicrobial Evaluation of Novel Benzimidazoleincorporated Naphthalimide Derivatives as
    Ning ZW; Zhang HZ; Zhou CH
    Med Chem; 2022; 18(5):544-557. PubMed ID: 34254924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity.
    Wu A; Xu Y; Qian X
    Bioorg Med Chem; 2009 Jan; 17(2):592-9. PubMed ID: 19109022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A naphthalimide-polyamine conjugate preferentially accumulates in hepatic carcinoma metastases as a lysosome-targeted antimetastatic agent.
    Ma J; Li L; Yue K; Zhang Z; Su S; Chen Y; Yu L; Zhang P; Ma R; Li Y; Ma Y; Jia H; Wang C; Wang J; Xie S
    Eur J Med Chem; 2021 Oct; 221():113469. PubMed ID: 33965862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleus-targeting imaging and enhanced cytotoxicity based on naphthalimide derivatives.
    Wang SS; Du SY; He X; Qi YM; Li XL; Rong RX; Cao ZR; Wang KR
    Bioorg Chem; 2021 Oct; 115():105188. PubMed ID: 34314915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis, and Evaluation of Novel 3-Carboranyl-1,8-Naphthalimide Derivatives as Potential Anticancer Agents.
    Rykowski S; Gurda-Woźna D; Orlicka-Płocka M; Fedoruk-Wyszomirska A; Giel-Pietraszuk M; Wyszko E; Kowalczyk A; Stączek P; Bak A; Kiliszek A; Rypniewski W; Olejniczak AB
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, in vitro evaluation and molecular modelling of naphthalimide analogue as anticancer agents.
    Verma M; Luxami V; Paul K
    Eur J Med Chem; 2013 Oct; 68():352-60. PubMed ID: 23994328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
    Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z
    Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
    Wu A; Xu Y; Qian X; Wang J; Liu J
    Eur J Med Chem; 2009 Nov; 44(11):4674-80. PubMed ID: 19643513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, Characterization, Quantum-Chemical Calculations and Cytotoxic Activity of 1,8-Naphthalimide Derivatives with Non-Protein Amino Acids.
    Marinov MN; Naydenova ED; Momekov GT; Prodanova RY; Markova NV; Voynikov YT; Stoyanov NM
    Anticancer Agents Med Chem; 2019; 19(10):1276-1284. PubMed ID: 30848212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction.
    Streciwilk W; Terenzi A; Cheng X; Hager L; Dabiri Y; Prochnow P; Bandow JE; Wölfl S; Keppler BK; Ott I
    Eur J Med Chem; 2018 Aug; 156():148-161. PubMed ID: 30006161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of naphthalimide-phenanthro[9,10-d]imidazole derivatives: In vitro evaluation, binding interaction with DNA and topoisomerase inhibition.
    Singh I; Luxami V; Paul K
    Bioorg Chem; 2020 Mar; 96():103631. PubMed ID: 32036164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA binding and anticancer activity of naphthalimides with 4-hydroxyl-alkylamine side chains at different lengths.
    Wang K; Wang Y; Yan X; Chen H; Ma G; Zhang P; Li J; Li X; Zhang J
    Bioorg Med Chem Lett; 2012 Jan; 22(2):937-41. PubMed ID: 22200595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of novel amonafide-polyamine conjugates as anticancer agents.
    Wang Y; Zhang J; Li M; Li M; Xie S; Wang C
    Chem Biol Drug Des; 2017 May; 89(5):670-680. PubMed ID: 27762101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, anticancer activity and DNA-binding properties of novel 4-pyrazolyl-1,8-naphthalimide derivatives.
    Li S; Xu S; Tang Y; Ding S; Zhang J; Wang S; Zhou G; Zhou C; Li X
    Bioorg Med Chem Lett; 2014 Jan; 24(2):586-90. PubMed ID: 24370011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and antitumor evaluation of morpholine substituted bisnaphthalimides as DNA targeting agents.
    Chen XM; Zhou JY; Liu SQ; Song LH; Wang HL; Wang Q; Liang SM; Lu L; Wei JH; Huang R; Zhang Y
    Bioorg Med Chem Lett; 2023 Apr; 85():129218. PubMed ID: 36894107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.